Anti-Neuropilin 1 antibody [EPR3113]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
4
(31 Reviews)
|
(184 Publications )
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 150 publications
- Trusted since 2009
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Immunohistochemical analysis of formalin fixed paraffin embedded human kidney labelling Neuropilin 1 with ab81321 at a concentration of 0.5µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH8.5 for 32mins. ab81321 Anti-Neuropilin 1 antibody [EPR3113] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control. Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Overlay histogram showing HepG2 cells stained with unpurified ab81321 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (unpurified ab81321, 1/50 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (0.5μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a significantly decreased signal in HepG2 cells fixed with methanol (5 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Immunocytochemistry/Immunofluorescence analysis of HUVEC cells labelling Neuropilin 1 with purified ab81321 at 1/250. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500) were also used.
Control 1 : primary antibody (1/250) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).
Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human liver tissue labelling Neuropilin 1 with purified ab81321 at 1/400. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Intracellular Flow Cytometry analysis of MCF7 cells labelling Neuropilin 1 with purified ab81321 at 1/70 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
The expression of Neuropilin 1, VEGFR-2, and VEGF was analyzed by immunofluorescence microscopy in omentum and effluent-derived mesothelial cells (MCs). MCs were double stained for Neuropilin 1 (green) and VEGFR-2 (red), and single stained for VEGF (green). Nuclei were stained with DAPI. Neuropilin 1 and VEGF show a membrane distribution in omentum and epithelioid MCs (b, c, h, i). During in vitro (e, f) and ex vivo (k, l) MMT both proteins change their localization and are internalized. The expression of VEGFR-2 is down-regulated but it does not show differences in localization during in vitro (a, d) and ex vivo (g, j) MMT.
Image from Pérez-Lozano ML et al., PLoS One. 2013;8(4):e60776. Fig 5.; doi: 10.1371/journal.pone.0060776.
- IP
Lab
Immunoprecipitation - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Neuropilin 1 was immunoprecipitated from 0.35mg mouse heart lysate with ab81321 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab81321 at 1/1000 dilution (0.77 μg/mL). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used as the secondary antibody at 1/1000 dilution.
Lane 1 : Mouse heart tissue lysate 10 μg
Lane 2 : Mouse heart tissue lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab81321 in mouse heart lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-Neuropilin 1 antibody [EPR3113] (ab81321)
Predicted band size: 103 kDa
Observed band size: 120 kDa
false
Exposure time: 4s
- WB
Unknown
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/1000 dilution
Lane 1:
Human placenta lysate at 10 µg
Lane 2:
HUVEC cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Lane 4:
Mouse heart tissue lysate at 10 µg
Lane 5:
Mouse kidney tissue lysate at 10 µg
Lane 6:
Rat heart tissue lysate at 10 µg
Lane 7:
Rat kidney tissue lysate at 10 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG at 1/2000 dilution
Predicted band size: 103 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/10000 dilution
All lanes:
Human heart tissue lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 103 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
False colour image of Western blot : Anti-Neuropilin 1 antibody [EPR3113] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab81321 was shown to bind specifically to Neuropilin 1. A band was observed at 125/135 kDa in wild-type A549 cell lysates with no signal observed at this size in NRP1 knockout cell line ab269507 (knockout cell lysate ab269669). To generate this image, wild-type and NRP1 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
NRP1 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human NRP1 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-nrp1-knockout-a549-cell-line-ab269507'>ab269507</a>)
Lane 3:
MDA-MB-231 cell lysate at 20 µg
Lane 4:
SK-BR-3 cell lysate at 20 µg
Predicted band size: 103 kDa
Observed band size: 125-135 kDa
false
- WB
Lab
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/2000 dilution
All lanes:
Human placenta tissue lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 103 kDa
Observed band size: 120 kDa
false
- WB
Lab
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
This blot was produced using 4-20% SDS-PAGE containing 15 μg of rat heart lysate per lane at 150V for 1hr before being transferred onto a 0.45 μm PVDF membrane at 75V for 1hr. The membrane was then blocked for 1hr using 5% NFDM/TBST, then incubated with ab81321 (1/10,000) at room temperature for 1hr. After being washed three times in TBST, the membrane was incubated with Peroxidase conjugated goat anti-rabbit IgG (H+L) (ab97051) at 1/20,000 dilution for 1hr at room temperature. The membrane was washed three times again. Then the signal was developed using the ECL technique.
ab81321 was stored at a range of temperatures (+4°C, +22°C, +37°C) for 1 week before being tested in WB. The image shows the band intensity remains relatively constant across all storage temperatures, demonstrating that antibody activity is not affected under these conditions. This data was generated as part of a structured antibody stability study supporting Abcam’s transition from cold‑chain to ambient shipping.
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/10000 dilution
All lanes:
Rat heart lysate at 15 µg with NDFM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 100s
- WB
Lab
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (AB81321)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Neuropilin 1 antibody [EPR3113] (ab81321) at 1/10000 dilution
Lane 1:
Mouse heart tissue lysate at 20 µg
Lane 2:
Rat heart tissue lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 103 kDa
Observed band size: 120 kDa
false
Related conjugates and formulations (8)
-
Anti-Neuropilin 1 antibody [EPR3113] - BSA and Azide free
-
660 APC
APC Anti-Neuropilin 1 antibody [EPR3113]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Neuropilin 1 antibody [EPR3113]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Neuropilin 1 antibody [EPR3113]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Neuropilin 1 antibody [EPR3113]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Neuropilin 1 antibody [EPR3113]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Neuropilin 1 antibody [EPR3113]
-
578 PE
PE Anti-Neuropilin 1 antibody [EPR3113]
Reactivity data
Product details
What is this antibody validated in?
Anti-Neuropilin 1 antibody [EPR3113] (ab81321) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.
What is the molecular weight of Neuropilin 1?
Anti-Neuropilin 1 [EPR3113] (ab81321) specifically detects a band for Neuropilin 1 (UniProt: O14786) at a molecular weight of 103kDa.
Trusted by the scientific community
Anti-Neuropilin 1 [EPR3113] (ab81321) was first used in a scientific publication in 2009 and has been cited over 150 times in peer-reviewed journals.
Reviewed by scientists
Anti-Neuropilin 1 [EPR3113] (ab81321) has over 30 independent reviews from customers.
Specificity confirmed
The specificity of Anti-Neuropilin 1 antibody [EPR3113] (ab81321) has been confirmed by Western blot testing in NRP1 Knockout A549 cell line, ab269507.
Other related products
We have a range of other formats of antibody clone [EPR3113] also available for your convenience: ab81321, Carrier free - ab184783, Alexa Fluor® 488 - ab197644, PE - ab209445, APC - ab310882, Alexa Fluor® 594 - ab311688, Alexa Fluor® 568 - ab312964, Alexa Fluor® 555 - ab313173, Alexa Fluor® 750 - ab321741
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Neuropilin-1 serves as a co-receptor for both the Vascular Endothelial Growth Factor (VEGF) and Semaphorin family proteins. It plays an important role in processes such as angiogenesis axonal guidance and the immune system. Neuropilin-1 does not function alone; it forms complexes with neuropilin-2 and other receptors like Plexin and VEGFR enhancing signal transduction pathways for angiogenesis and neuronal development. This involvement allows cells to respond appropriately to their environment especially during organismal development and repair processes.
Pathways
Neuropilin-1 facilitates interactions within the VEGF and Semaphorin pathways. In the VEGF pathway Neuropilin-1 enhances binding and signaling efficiency with VEGF closely working alongside VEGFR to promote endothelial cell survival migration and new blood vessel formation. In the Semaphorin pathway Neuropilin-1 interacts with Plexins mediating neuronal pathfinding and axonal growth. These interactions highlight Neuropilin-1's adaptive capabilities in various physiological processes critical for system development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (184)
Recent publications for all applications. Explore the full list and refine your search
Molecular and clinical oncology 23:92 PubMed40900735
2025
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 17: PubMed40872854
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40805120
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 25:179 PubMed40380175
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 25:678 PubMed40316997
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:54 PubMed39875894
2025
Applications
Unspecified application
Species
Unspecified reactive species
Small methods 9:e2401588 PubMed39871784
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 14:5680-5696 PubMed39803652
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 13:4 PubMed39746903
2025
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 26:218-244 PubMed39609640
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com